Brought to you by 
Molecular Partners raises CHF18.5mm in first venture round
28 Aug 2007
Executive Summary
Swiss start-up Molecular Partners AG has raised CHF18.5mm ($15.6mm) through its Series A financing, which was led by Index Ventures and included BB Biotech Ventures, Johnson & Johnson Development Corp., and Endeavour. Index contributes two new members to the company's board.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Molecular Partners raises CHF18.5mm in first venture round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice